Clinical Trial Update: Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated bendamustine given concurrently with whole-brain radiation for brain metastases from solid tumors. The trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Drugs mentioned

• Bendamustine (Bendamustine)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Brain Metastases | Phase 1 | Status: TERMINATED